The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
World Health Organization (WHO) guidelines call for all people newly diagnosed to start treatment straight away – but worrying numbers of people in high-burden countries still test and present late to care.
First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.
In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older
HIV is the leading cause of death for women of reproductive age and Washington-led health policies show a lack of understanding of the realities and importance of health service integration on the ground.
There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?
Weaker health systems and psychosocial factors may explain the differences in adherence patterns between Asia and Africa, the world’s two most HIV-affected regions.
‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.
Drug trial results for new integrase inhibitor show promising viral suppression rates.
One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.
HIV home-testing kits are available in a growing number of countries. They offer you the convenience of taking an HIV test in your own time and in the privacy of your own home – but are they for everyone?